3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Radiation Injuries
1
Prostate Adenocarcinoma
1
Lymphatic Metastasis
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Interventions
Radiotherapy
7
Heavy Ion Radiotherapy
3
Radiosurgery
2
Proton Therapy
2
Chemoradiotherapy
2
Blood Specimen Collection
2
sodium propionate
1
lithium sulfate
1
Xylitol
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Patient Reported Outcome Measures
1
Neuropsychological Tests
1
Lymph Node Excision
1
Lithium
1
Lisinopril
1
Fatty Acids, Volatile
1
Etoposide
1
Dexamethasone
1
Consolidation Chemotherapy
1
Cisplatin
1
Carboplatin
1
Butyric Acid
1
Bevacizumab
1
Betaine
1
Base Sequence
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Radiation Injuries
×
Lymph Node Excision
×
Clear all
NCT04889924
2026-05-19
ADARNAT
Hospital Universitari de Bellvitge
Phase NA
Recruiting
820 enrolled